-
Symbol
-
SLXN on Nasdaq
-
Investment type
-
Equity / Ordinary shares, par value $0.0135 per share
-
Latest Disclosed Shares Owned
-
456,531 shares
-
Security Ownership %
-
4.9%
CVI Investments, Inc. ownership in Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN)
12 May 2025 - CVI Investments, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 456,531 shares of Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN).
This represents 4.9% ownership of the company.
In their previous filing dated 23 Jan 2025, CVI Investments, Inc. had reported owning 339,000 shares, indicating an increase of +35%.
.